Leg Cramps NDC 54973-2956

NDC codes

FDA NDC Directory

Product NDC (as listed)54973-2956Labeler and product segments. Claims need a package NDC.

Product NDC at billing width54973-2956Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
54973-2956-1	54973295601	1 BOTTLE, PLASTIC in 1 CARTON (54973-2956-1) / 50 TABLET, SOLUBLE in 1 BOTTLE, PLASTICMarketed from Dec 4, 1995
54973-2956-2	54973295602	1 BOTTLE, PLASTIC in 1 CARTON (54973-2956-2) / 100 TABLET, SOLUBLE in 1 BOTTLE, PLASTICMarketed from Dec 4, 1995
54973-2956-4	54973295604	4 PACKET in 1 CARTON (54973-2956-4) / 4 TABLET, SOLUBLE in 1 PACKETMarketed from Aug 1, 2018
54973-2956-6	54973295606	1 BOTTLE, PLASTIC in 1 CARTON (54973-2956-6) / 100 TABLET, SOLUBLE in 1 BOTTLE, PLASTICMarketed from Dec 4, 1995

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Leg Cramps
Generic name (nonproprietary): cinchona officinalis bark, aconitum napellus, pseudognaphalium obtusifolium, ledum palustre twig, magnesium phosphate, dibasic trihydrate, toxicodendron pubescens leaf, and viscum album fruiting top
Active ingredients: Cinchona officinalis bark — 3 [hp_X]/1Aconitum napellus — 6 [hp_X]/1Pseudognaphalium obtusifolium — 3 [hp_X]/1Ledum palustre twig — 6 [hp_X]/1Magnesium phosphate, Dibasic trihydrate — 6 [hp_X]/1Toxicodendron pubescens leaf — 6 [hp_X]/1Viscum album fruiting top — 3 [hp_X]/1
Dosage form: Tablet, Soluble
Route: Oral
Labeler: Hyland's Consumer Health Inc.
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Dec 4, 1995
Listing expires: Dec 31, 2027
Other FDA classes: Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Osmotic Activity (Mechanism)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
Identifiers: Product ID 54973-2956_59465986-21d6-30f8-e063-6294a90aceaaSPL ID 59465986-21d6-30f8-e063-6294a90aceaaSPL set ID 53425c3b-6117-475c-bd8c-08f05b452078UNII S003A158SB, U0NQ8555JD, 36XQ854NWW, 877L01IZ0P, HF539G9L3Q, 6IO182RP7A, BK9092J5MP
Pharmacologic class: Calculi Dissolution Agent; Osmotic Laxative

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N454973295601 followed by a unit qualifier and the quantity

Package 54973-2956-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 17, 2026.

Indications (excerpt from the label)

Uses ■ Helps temporarily relieves the symptoms of: ■ stiffness ■ pain in limbs, joints or legs ■ cramps in calves, feet or legs

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)